4.8 Article

The EMT Transcription Factor ZEB2 Promotes Proliferation of Primary and Metastatic Melanoma While Suppressing an Invasive, Mesenchymal-Like Phenotype

Journal

CANCER RESEARCH
Volume 80, Issue 14, Pages 2983-2995

Publisher

AMER ASSOC CANCER RESEARCH
DOI: 10.1158/0008-5472.CAN-19-2373

Keywords

-

Categories

Funding

  1. Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)
  2. Kom op tegen Kanker
  3. Fonds Wetenschappelijk Onderzoek [3G050217W]
  4. Strategic Basic Research (SBO) [S008518N]
  5. Geconcerteerde Onderzoeksacties Ghent University [GOA-01GB1013W]
  6. Vlaamse Liga tegen Kanker [365U8914U]
  7. Stichting tegen Kanker [FAF-F/2016/814]

Ask authors/readers for more resources

Epithelial-to-mesenchymal transition (EMT)-inducing transcription factors (TF) are well known for their ability to induce mesenchymal states associated with increased migratory and invasive properties. Unexpectedly, nuclear expression of the EMT-TF ZEB2 in human primary melanoma has been shown to correlate with reduced invasion. We report here that ZEB2 is required for outgrowth for primary melanomas and metastases at secondary sites. Ablation of Zeb2 hampered outgrowth of primary melanomas in vivo, whereas ectopic expression enhanced proliferation and growth at both primary and secondary sites. Gain of Zeb2 expression in pulmonary-residing melanoma cells promoted the development of macroscopic lesions. In vivo fate mapping made clear that melanoma cells undergo a conversion in state where ZEB2 expression is replaced by ZEB1 expression associated with gain of an invasive phenotype. These findings suggest that reversible switching of the ZEB2/ZEB1 ratio enhances melanoma metastatic dissemination.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available